Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by fringelifeon Dec 19, 2016 9:11pm

49 Views

Post# 25622417

RE:Nf is Not Down Due to Tax Loss

I just meant today mostly and that it wasn't much different than the rest of the stocks in this sector. There's other factors, one of them was the fact it went up so fast it made it an obvious target for short sellers and profit taking. The CEO sell off didn't help either, but today's factor seems to be just following the trend that the rest of the sector is following.

Bullboard Posts

How one company is disrupting PoC testing